| Enalapril/Lercanidipine Krka 20 mg/10 mg film-coated tablets PA1347/029/002 |
Enalapril maleate, Lercanidipine |
KRKA, d.d., Novo mesto |
Marketed |
| ENAP 10 mg tablets PA0711/028/002 |
Enalapril maleate |
Rowex Limited, |
Marketed |
| ENAP 20 mg tablets PA0711/028/003 |
Enalapril maleate |
Rowex Limited, |
Marketed |
| ENAP 5 mg tablets PA0711/028/001 |
Enalapril maleate |
Rowex Limited, |
Marketed |
| Enbrel 10 mg Powder and solvent for solution for injection EU/1/99/126/022 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Powder for solution for injection EU/1/99/126/001-003 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Powder for solution for injection EU/1/99/126/002 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Solution for injection EU/1/99/126/013-015 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 25 mg Solution for injection EU/1/99/126/023-025 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| Enbrel 50 mg Solution for injection EU/1/99/126/016-021 |
Etanercept |
Pfizer Europe MA EEIG |
— |
| EndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solution EU/1/16/1105/001-002 |
Lutetium (177lu) chloride |
ITM Medical Isotopes GmbH |
— |
| Endoxana Coated Tablets 50 mg PA2299/027/003 |
Cyclophosphamide monohydrate |
Baxter Holding B.V. |
Marketed |
| Endoxana Injection 1000 mg Powder for Solution for Injection PA2299/027/002 |
Cyclophosphamide |
Baxter Holding B.V. |
Marketed |
| Endoxana Injection 500 mg Powder for Solution for Injection PA2299/027/001 |
Cyclophosphamide |
Baxter Holding B.V. |
Marketed |
| Enerzair Breezhaler 114 micrograms/46 micrograms/136 micrograms inhalation powder, hard capsules EU/1/20/1438/001-005 |
Indacaterol acetate, Glycopyrronium bromide, Mometasone furoate |
Novartis Europharm Limited |
— |
| Engerix B 20 micrograms/1 ml Suspension for injection in pre-filled syringe Hepatitis B (rDNA) vaccine (adsorbed) (HBV) PA1077/023/002 |
Hepatitis b surface antigen, recominant |
GlaxoSmithKline (Ireland) Limited |
Marketed |
| Enhertu 100 mg powder for concentrate for solution for infusion EU/1/20/1508/001 |
Trastuzumab Deruxtecan |
Daiichi Sankyo Europe GmbH |
— |
| Enjaymo 50 mg/mL solution for infusion EU/1/22/1687/001-002 |
Sutimlimab |
Recordati Rare Diseases |
— |
| Enoxaparin sodium Ledraxen 10,000 IU (100 mg)/1 mL, solution for injection in pre-filled syringe PA23258/001/001 |
Enoxaparin sodium |
Venipharm |
Not marketed |
| Enoxaparin sodium Ledraxen 2,000 IU (20 mg)/0.2 mL, solution for injection in pre-filled syringe PA23258/001/005 |
Enoxaparin sodium |
Venipharm |
Not marketed |
| Enoxaparin sodium Ledraxen 4,000 IU (40 mg)/0.4 mL, solution for injection in pre-filled syringe PA23258/001/004 |
Enoxaparin sodium |
Venipharm |
Not marketed |
| Enoxaparin sodium Ledraxen 6,000 IU (60 mg)/0.6 mL, solution for injection in pre-filled syringe PA23258/001/003 |
Enoxaparin sodium |
Venipharm |
Not marketed |
| Enoxaparin sodium Ledraxen 8,000 IU (80 mg)/0.8 mL, solution for injection in pre-filled syringe PA23258/001/002 |
Enoxaparin sodium |
Venipharm |
Not marketed |
| Enrylaze 10 mg/0.5 mL solution for injection/infusion. EU/1/23/1747/001 |
Crisantaspase |
Jazz Pharmaceuticals Ireland Limited |
— |
| Enspryng 120 mg solution for injection in pre-filled syringe EU/1/21/1559/001 |
Satralizumab |
Roche Registration GmbH |
— |
| Enstilar 50 micrograms/g + 0.5 mg/g cutaneous foam PA1025/005/001 |
Calcipotriol, Betamethasone |
LEO Pharma A/S |
Marketed |
| Entacapone Orion 200 mg film-coated tablets EU/1/11/708/001-004 |
Entacapone |
Orion Corporation |
— |
| Entacapone Teva 200 mg film-coated tablets EU/1/10/665/001-004 |
Entacapone |
Teva Pharma B.V. |
— |
| Entecavir Accord 0.5 mg film-coated tablets EU/1/17/1211/001-003 |
Entecavir |
Accord Healthcare S.L.U. |
— |
| Entecavir Accord 1 mg film-coated tablets EU/1/17/1211/004-006 |
Entecavir |
Accord Healthcare S.L.U. |
— |
| Entecavir Rowex 0.5 mg Film-coated tablets PA0711/274/001 |
ENTECAVIR MONOHYDRATE |
Rowex Ltd |
Marketed |
| Entecavir Viatris 0.5 mg Film-coated tablet EU/1/17/1227/001-005 |
Entecavir |
Viatris Limited |
— |
| Entecavir Viatris 1 mg film-coated tablets EU/1/17/1227/006-010 |
Entecavir |
Viatris Limited |
— |
| Entocort CR 3 mg Gastro-resistant Capsule, Hard PA2018/003/001 |
Budesonide |
Tillotts Pharma GmbH |
Marketed |
| Entonox PA0208/005/001 |
Oxygen, Nitrous oxide |
BOC Gases Ireland Ltd |
Marketed |
| Entresto 24 mg/26 mg film-coated tablets EU/1/15/1058/001 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Entresto 49 mg/51 mg film-coated tablets EU/1/15/1058/002-004 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Entresto 6 mg/6 mg granules in capsules for opening EU/1/15/1058/023 |
Sacubitril, Valsartan |
Novartis Europharm Limited |
— |
| Entresto 97 mg/103 mg film-coated tablets EU/1/15/1058/005-007 |
Sacubitril valsartan |
Novartis Europharm Limited |
— |
| Entyvio 108 mg solution for injection in pre-filled pen EU/1/14/923/005-007 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Entyvio 108 mg solution for injection in pre-filled syringe EU/1/14/923/002-004 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Entyvio 300 mg powder for concentrate for solution for infusion EU/1/14/923/001 |
Vedolizumab |
Takeda Pharma A/S |
— |
| Enurev Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/789/001-006 |
Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Envarsus 0.75 mg prolonged-release tablets EU/1/14/35/001-003 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 1 mg prolonged-release tablets EU/1/14/35/004-006 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 4 mg prolonged-release tablets EU/1/14/35/007-009 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Enwylma 120 mg solution for injection EU/1/25/1944/001 |
Denosumab |
Zentiva k.s. |
— |
| Enyglid 0.5 mg tablets EU/1/09/580/1-6 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Enyglid 1 mg tablets EU/1/09/580/7-12 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |
| Enyglid 2 mg tablets EU/1/09/580/13-18 |
Repaglinide |
KRKA, d.d., Novo mesto |
— |